HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LEADS BIOLABS-B

52.050

+1.6503.27%

Volume:698.10K

Turnover:36.09M

Market Cap:10.36B

PE:-36.81

High:52.350

Open:50.650

Low:50.150

Close:50.400

52wk High:97.500

52wk Low:44.720

Shares:199.00M

HK Float Shares:198.00M

Volume Ratio:0.43

T/O Rate:0.35%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.414

ROE:-51.55%

ROA:-12.87%

PB:9.52

PE(LYR):-36.81

PS:41.57

Loading ...

Overview Company News Filings

LEADS BIOLABS-B (09887) Shares Rise Over 2% as Core Product Vilixin Secures Orphan Drug Designation in Japan

Hong Kong Stock Announcements: Four New Listings Debut Today Including Robotechnik and Kinwong; GAC Group Plans A-Share Issuance to Acquire 50% Stake in GAC Toyota

Hong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%

MT Newswires Live

Leads Biolabs' Pd-L1/4-1Bb Bispecific Antibody Opamtistomig (Lbl-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

THOMSON REUTERS

Nanjing Leads Biolabs' Cancer Therapy Gets Orphan Drug Status in Japan; Shares Fall 5%

MT Newswires Live

LEADS BIOLABS-B (09887) Core Product VELIXIN Receives Orphan Drug Designation in Japan

Nanjing Leads Biolabs Co - Lbl-024 Granted Orphan Drug Designation by Mhlw in Japan for Ep-Nec

THOMSON REUTERS

Is LEADS BIOLABS-B (09887), in a Sustained One-Way Decline, Getting Closer to a Key Turning Point for Its Next Move?

Movement Alert｜LEADS BIOLABS-B Falls 5.6% in Regular Trading, Biotech Sector Weakness Compounds Post-Volatility Profit-Taking

LEADS BIOLABS-B Posts Wider Interim Loss as NDA for Core Asset LBL-024 Enters Priority Review

Bulletin Express

Movement Alert｜LEADS BIOLABS-B Rises 5.54% in Regular Trading, ESMO Late-Breaking Abstract Selection Drives Rebound After Prior Session Sell-Off

Nanjing Leads Biolabs to Present Rare Lung Cancer Study Papers at 2026 ESMO; Shares Fall 3%

MT Newswires Live

Movement Alert｜LEADS BIOLABS-B Falls 5.59% in Regular Trading, Profit-Taking and Incentive Platform Stake Reduction Weigh on Shares Despite Positive ESMO Data

Leads Biolabs Submits China NDA for Opamtistomig in Advanced EP-NEC

LEADS BIOLABS-B Secures LBA Selection and Three Proffered Paper Presentations at ESMO 2026 for Lead Assets

LEADS BIOLABS-B: Xiaoqiang Kang Disposes of Shares, Long Position Falls to 14.93%

Movement Alert｜LEADS BIOLABS-B Rises 5.29% in Regular Trading, Morgan Stanley Upgrade and WCLC Data Continue to Drive Rebound

Hong Kong Market Movers | LEADS BIOLABS-B (09887) Climbs Over 6% Pre-Noon as PD-L1/4-1BB Bispecific Antibody Unveils Updated Data at WCLC, Domestic Launch of LBL-024 Imminent

Movement Alert｜LEADS BIOLABS-B Rises 5.55% in Regular Trading, Technical Rebound After Two-Day Post-WCLC Pullback

Movement Alert｜LEADS BIOLABS-B Falls 6.04% in Regular Trading, Stock Extends Post-WCLC Sell-the-News Pullback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/09887/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":52.05,"timestamp":1790755707009,"preClose":50.4,"halted":0,"volume":698100,"delay":0,"changeRate":0.03273809523809521,"floatShares":198000000,"shares":199000000,"eps":-1.4140101375473726,"marketStatus":"Closed National Day","change":1.65,"latestTime":"09-30 16:08:27","open":50.65,"high":52.35,"low":50.15,"amount":36092305,"amplitude":0.043651,"askPrice":52.05,"askSize":5900,"bidPrice":52,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-1.6092276759751112,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":50.4,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0.42945670677487274,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":198000000,"roa":"-12.87%","roe":"-51.55%","lyrEps":-1.41401,"volumeRatio":0.42945670677487274,"shares":199000000,"dividePrice":0,"high":52.35,"amplitude":0.043651,"preClose":50.4,"low":50.15,"week52Low":44.72,"pbRate":"9.52","psRate":"41.57","week52High":97.5,"institutionHeld":0,"latestPrice":52.05,"committee":-0.594595,"eps":-1.4140101375473726,"divideRate":0,"volume":698100,"delay":0,"ttmEps":-1.6092276759751112,"open":50.65,"prevYearClose":51,"prevWeekClose":52.3,"prevMonthClose":52.05,"prevQuarterClose":52.05,"fiveDayClose":56.2,"twentyDayClose":66.95,"sixtyDayClose":49.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-27","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1789574400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2026-09-29","current":-32.317257,"percent":0.97931,"low":-76.458084,"twenty":-45.107477,"median":-39.795494,"eighty":-34.534018,"high":-30.202688,"avg":-41.750483,"sd":9.612091,"marketCap":9834128640},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-21","current":-32.263354,"twenty":-43.773799,"median":-41.293984,"eighty":-37.626872,"marketCap":10143481800},{"date":"2025-11-28","current":-33.407237,"twenty":-43.416049,"median":-41.25873,"eighty":-37.278832,"marketCap":10541265400},{"date":"2025-12-05","current":-32.531883,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"marketCap":10282706060},{"date":"2025-12-12","current":-33.445348,"twenty":-43.033782,"median":-40.504976,"eighty":-34.804627,"marketCap":10590988350},{"date":"2025-12-19","current":-31.455565,"twenty":-42.962519,"median":-40.253447,"eighty":-33.697999,"marketCap":9984368360},{"date":"2025-12-24","current":-31.920084,"twenty":-42.892338,"median":-39.907071,"eighty":-33.445348,"marketCap":10163370980},{"date":"2026-01-02","current":-31.421623,"twenty":-42.818917,"median":-39.811672,"eighty":-33.24713,"marketCap":10044035900},{"date":"2026-01-09","current":-34.757237,"twenty":-42.712093,"median":-39.628079,"eighty":-33.303022,"marketCap":11137940800},{"date":"2026-01-16","current":-34.953981,"twenty":-42.570843,"median":-39.220132,"eighty":-33.387129,"marketCap":11237386700},{"date":"2026-01-23","current":-34.708884,"twenty":-42.534258,"median":-38.04671,"eighty":-33.234922,"marketCap":11147885390},{"date":"2026-01-30","current":-41.208386,"twenty":-42.402729,"median":-37.93488,"eighty":-33.285275,"marketCap":13295916830},{"date":"2026-02-06","current":-38.552413,"twenty":-42.362692,"median":-38.04671,"eighty":-33.303022,"marketCap":12470515860},{"date":"2026-02-13","current":-37.506904,"twenty":-42.335079,"median":-38.011119,"eighty":-33.387129,"marketCap":12202011930},{"date":"2026-02-20","current":-39.795685,"twenty":-42.275235,"median":-38.202679,"eighty":-33.413439,"marketCap":12927967000},{"date":"2026-02-27","current":-37.9711,"twenty":-42.061223,"median":-38.358648,"eighty":-33.438876,"marketCap":12470515860},{"date":"2026-03-06","current":-32.876582,"twenty":-42.035836,"median":-37.973315,"eighty":-33.326804,"marketCap":10710323430},{"date":"2026-03-13","current":-37.800338,"twenty":-41.938243,"median":-37.9711,"eighty":-33.411645,"marketCap":12371069960},{"date":"2026-03-20","current":-39.652105,"twenty":-41.914066,"median":-38.162788,"eighty":-33.431073,"marketCap":12927967000},{"date":"2026-03-27","current":-45.563334,"twenty":-41.938243,"median":-38.422097,"eighty":-33.438876,"marketCap":14817439100},{"date":"2026-04-02","current":-73.055706,"twenty":-42.061577,"median":-38.676054,"eighty":-33.441386,"marketCap":17572695150},{"date":"2026-04-10","current":-74.98239,"twenty":-42.364587,"median":-38.815397,"eighty":-33.443763,"marketCap":18175244000},{"date":"2026-04-17","current":-69.940613,"twenty":-42.73421,"median":-39.081216,"eighty":-33.482556,"marketCap":16960268450},{"date":"2026-04-24","current":-67.940785,"twenty":-43.090538,"median":-39.261059,"eighty":-33.558052,"marketCap":16476253800},{"date":"2026-04-30","current":-65.13036,"twenty":-44.026925,"median":-39.582143,"eighty":-33.605745,"marketCap":15804560000},{"date":"2026-05-08","current":-55.847576,"twenty":-44.547984,"median":-39.760016,"eighty":-33.640661,"marketCap":16030679080},{"date":"2026-05-15","current":-43.849045,"twenty":-45.37348,"median":-39.795589,"eighty":-33.697999,"marketCap":12619684710},{"date":"2026-05-22","current":-44.434352,"twenty":-44.931837,"median":-39.87359,"eighty":-33.778461,"marketCap":12758908970},{"date":"2026-05-29","current":-42.313126,"twenty":-44.693978,"median":-39.965338,"eighty":-33.850015,"marketCap":12192067340},{"date":"2026-06-05","current":-38.943344,"twenty":-44.633844,"median":-39.952945,"eighty":-33.989804,"marketCap":11237386700},{"date":"2026-06-12","current":-37.176407,"twenty":-44.416359,"median":-39.831455,"eighty":-34.116239,"marketCap":10720268020},{"date":"2026-06-18","current":-37.166904,"twenty":-44.344385,"median":-39.795685,"eighty":-34.459057,"marketCap":10740157200},{"date":"2026-06-26","current":-34.282345,"twenty":-44.322103,"median":-39.774315,"eighty":-34.282345,"marketCap":9861055444},{"date":"2026-07-03","current":-36.446991,"twenty":-44.194662,"median":-39.640092,"eighty":-34.070689,"marketCap":10491542450},{"date":"2026-07-10","current":-34.534018,"twenty":-44.124681,"median":-39.536207,"eighty":-34.070689,"marketCap":9928678656},{"date":"2026-07-17","current":-44.462046,"twenty":-44.326559,"median":-39.640092,"eighty":-34.242022,"marketCap":12828521100},{"date":"2026-07-24","current":-43.03924,"twenty":-44.356568,"median":-39.788614,"eighty":-34.393423,"marketCap":12420792910},{"date":"2026-07-31","current":-36.732388,"twenty":-44.331016,"median":-39.652105,"eighty":-34.443911,"marketCap":10620822120},{"date":"2026-08-07","current":-44.144483,"twenty":-44.255348,"median":-39.774315,"eighty":-34.478204,"marketCap":12788742740},{"date":"2026-08-14","current":-50.259709,"twenty":-44.44543,"median":-39.795685,"eighty":-34.516798,"marketCap":14578768940},{"date":"2026-08-21","current":-48.712147,"twenty":-45.096211,"median":-39.845109,"eighty":-34.555887,"marketCap":14161096160},{"date":"2026-08-28","current":-49.214108,"twenty":-45.572671,"median":-39.940552,"eighty":-34.653517,"marketCap":14310265010},{"date":"2026-09-04","current":-40.091985,"twenty":-45.572671,"median":-40.024301,"eighty":-34.737896,"marketCap":12487782400},{"date":"2026-09-11","current":-37.6607,"twenty":-45.564242,"median":-39.940552,"eighty":-34.761336,"marketCap":11746320320},{"date":"2026-09-18","current":-34.8313,"twenty":-45.532372,"median":-39.845109,"eighty":-34.761336,"marketCap":10878029200},{"date":"2026-09-25","current":-32.738215,"twenty":-45.269178,"median":-39.795685,"eighty":-34.653517,"marketCap":10204859680},{"date":"2026-09-29","current":-31.505104,"twenty":-45.107477,"median":-39.795494,"eighty":-34.534018,"marketCap":9834128640}],"updateTime":1790798859536},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161529873","title":"LEADS BIOLABS-B (09887) Shares Rise Over 2% as Core Product Vilixin Secures Orphan Drug Designation in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=1161529873","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161529873?lang=en_us&edition=fundamental","pubTime":"2026-09-30 09:52","pubTimestamp":1790733133,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) shares climbed more than 2%, trading up 1.69% at HK$51.25 as of press time, with a turnover of HK$3.5403 million. On the news front, on September 28, LEADS BIOLABS-B issued an...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","09887","BK4585","BK4588","KCAI","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133058267","title":"Hong Kong Stock Announcements: Four New Listings Debut Today Including Robotechnik and Kinwong; GAC Group Plans A-Share Issuance to Acquire 50% Stake in GAC Toyota","url":"https://stock-news.laohu8.com/highlight/detail?id=1133058267","media":"Stock News","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133058267?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:06","pubTimestamp":1790644014,"startTime":"0","endTime":"0","summary":"GAC Group (02238) intends to acquire a 50% equity interest in GAC Toyota, with GAC Motor becoming the second-largest shareholder.NetDragon (00777) has entered into a memorandum with Jiuzhou to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603650","300757","BK1161","BK1109","BK1535","LU0359201612.USD","BK1610","BK1615","LU1152091754.HKD","TM","600026","06731","09887","LU0359202008.SGD","BK1179","03160","03757","BK1519","LU1993786604.SGD","BK4555","LU0880133367.SGD","LU1807302812.USD","BK4099","BK1119","BK1170","LU1152091168.USD","LU0307460666.USD","SG9999014674.SGD","BK1539","BK1110","BK1531","03750","00053","GULRY","BK1166","BK4585","601238","02635","300750","HK0000500386.USD","01138","02238","BK1183","00020","BK4604","BK4588","HK0000252152.HKD","LU0588546209.SGD","LU1008478684.HKD","80020","03228","BK1148","LU1023057109.AUD","603228","00777","09607","BK1104","BK1116","BK1526","BK1230","LU1960683339.HKD","BK1613","HK0000252160.HKD","LU0067412154.USD","LU0359201885.HKD","00331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280014","title":"Hong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670280014?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:51","pubTimestamp":1790585483,"startTime":"0","endTime":"0","summary":"Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.The Hang Seng Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng China Enterprises Index gained 51.06 points, or 0.6%, to 8,216.84.Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.In company news, Nanjing Leads Biolabs'  cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HSCEI","HSTECH","02828","02800","03423","07288","03417","83115","07500","03088","09115","03037","HSI","09887","07300","07588","03033","02833","02837","02802","82800","HHImain","03416","HK0000500386.USD","07200","HK0000252160.HKD","MHImain","MCHmain","BK1161","03067","07226","82828","03032","03419","09088","513600","HK0000252152.HKD","03115","09067","07552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670281430","title":"Leads Biolabs' Pd-L1/4-1Bb Bispecific Antibody Opamtistomig (Lbl-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2670281430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670281430?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:49","pubTimestamp":1790578198,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA2V0WWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09887","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670289240","title":"Nanjing Leads Biolabs' Cancer Therapy Gets Orphan Drug Status in Japan; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670289240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670289240?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:19","pubTimestamp":1790576372,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs  said its cancer treatment, LBL-024, has received orphan drug status in Japan, according to a Monday bourse filing.The biotechnology company said its treatment has now been assigned the special designation in three key markets, including the United States and Europe.The latest move by Japanese health regulators will make the drug eligible for various incentives in the country and help in bringing the treatment faster to commercial markets.Shares were last down nearly 5% in afternoon trading","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000252152.HKD","09887","HK0000252160.HKD","HK0000500386.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184878985","title":"LEADS BIOLABS-B (09887) Core Product VELIXIN Receives Orphan Drug Designation in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=1184878985","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184878985?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:22","pubTimestamp":1790569335,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) announced that its core product VELIXIN (opaptisumab, a PD-L1/4-1BB bispecific antibody) has been granted orphan drug designation by Japan's Ministry of Health, Labour and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","09887","HK0000500386.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428300","title":"Nanjing Leads Biolabs Co - Lbl-024 Granted Orphan Drug Designation by Mhlw in Japan for Ep-Nec","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428300?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:13","pubTimestamp":1790568825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I09A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","09887","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117439089","title":"Is LEADS BIOLABS-B (09887), in a Sustained One-Way Decline, Getting Closer to a Key Turning Point for Its Next Move?","url":"https://stock-news.laohu8.com/highlight/detail?id=1117439089","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117439089?lang=en_us&edition=fundamental","pubTime":"2026-09-26 14:14","pubTimestamp":1790403272,"startTime":"0","endTime":"0","summary":"Recently, the core asset of LEADS BIOLABS-B (09887), Virelimab® (opapatusumimab, a PD-L1/4-1BB bispecific antibody), has attracted significant attention in the international academic community.On...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK1161","HK0000500386.USD","09887","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103639728","title":"Movement Alert｜LEADS BIOLABS-B Falls 5.6% in Regular Trading, Biotech Sector Weakness Compounds Post-Volatility Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1103639728","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103639728?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:48","pubTimestamp":1790214529,"startTime":"0","endTime":"0","summary":"On September 24, LEADS BIOLABS-B fell 5.6% in regular trading, trading at HK$53.2/share, with turnover of HK$25.81 million.The decline came amid broad weakness across the biotechnology sector. Within...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LEADS BIOLABS-B Slumps as Employee Platform Sells 859,100 Shares","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176944391","title":"LEADS BIOLABS-B Posts Wider Interim Loss as NDA for Core Asset LBL-024 Enters Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1176944391","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176944391?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:02","pubTimestamp":1790172149,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B reported its first operating revenue yet booked a broader net loss for the six months ended 30 June 2026, while advancing flagship oncology antibody LBL-024 toward a potential...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LEADS BIOLABS-B Posts Wider Interim Loss as NDA for Core Asset LBL-024 Enters Priority Review","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176221914","title":"Movement Alert｜LEADS BIOLABS-B Rises 5.54% in Regular Trading, ESMO Late-Breaking Abstract Selection Drives Rebound After Prior Session Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1176221914","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176221914?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:12","pubTimestamp":1790140349,"startTime":"0","endTime":"0","summary":"On September 23, LEADS BIOLABS-B rose 5.54% in regular trading, trading at approximately 57.15 HKD/share, with turnover of approximately 72.10 million HKD. The rally was driven by the continued...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ESMO Late-Breaking Abstract Lifts LEADS BIOLABS-B Rebound","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669311825","title":"Nanjing Leads Biolabs to Present Rare Lung Cancer Study Papers at 2026 ESMO; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669311825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669311825?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:02","pubTimestamp":1790049756,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs  will present a paper on its phase IIb study of its drug to treat a rare form of lung cancer, LBL-024, at this year's European Society for Medical Oncology annual meeting, according to a Monday filing with the bourse.The biotech company said it was chosen to present three studies overall at the medical conference, reflecting the importance of its clinical research in treating patients with advanced extrapulmonary neuroendocrine carcinoma.Shares were down 3% in recent trading on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","HK0000252160.HKD","HK0000500386.USD","09887","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110270159","title":"Movement Alert｜LEADS BIOLABS-B Falls 5.59% in Regular Trading, Profit-Taking and Incentive Platform Stake Reduction Weigh on Shares Despite Positive ESMO Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1110270159","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110270159?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:41","pubTimestamp":1790041273,"startTime":"0","endTime":"0","summary":"On September 22, LEADS BIOLABS-B fell 5.59% in regular trading, trading at 53.7 HKD/share, with turnover of approximately 22.15 million HKD, as profit-taking pressure emerged following a string of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Morgan Stanley Upgrades LEADS BIOLABS-B to Overweight","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430162","title":"Leads Biolabs Submits China NDA for Opamtistomig in Advanced EP-NEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669430162?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:34","pubTimestamp":1790008468,"startTime":"0","endTime":"0","summary":"Leads Biolabs submits China NDA for opamtistomig in advanced EP-NECLeads Biolabs filed an NDA with China’s NMPA for opamtistomig (LBL-024) in advanced extrapulmonary neuroendocrine carcinoma.The filin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL143BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","HK0000252152.HKD","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","BK4112","NDAQ","HK0000252160.HKD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","HK0000500386.USD","IE00BN0W2T93.GBP","09887","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189323132","title":"LEADS BIOLABS-B Secures LBA Selection and Three Proffered Paper Presentations at ESMO 2026 for Lead Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1189323132","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189323132?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:20","pubTimestamp":1790000416,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) has announced that its pivotal registrational Phase IIb study evaluating Vilitrin (Opasci sumab, PD-L1/4-1BB bispecific antibody) as a monotherapy for advanced extrapulmonary...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","HK0000252160.HKD","09887","BK1161","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162615424","title":"LEADS BIOLABS-B: Xiaoqiang Kang Disposes of Shares, Long Position Falls to 14.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162615424","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162615424?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:42","pubTimestamp":1789983742,"startTime":"0","endTime":"0","summary":"On September 15, 2026, Xiaoqiang Kang, through Lizi Partnership (a controlled entity and share incentive platform), disposed of 859,100 shares of LEADS BIOLABS-B (09887) on the SEHK open market at an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135748403","title":"Movement Alert｜LEADS BIOLABS-B Rises 5.29% in Regular Trading, Morgan Stanley Upgrade and WCLC Data Continue to Drive Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1135748403","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135748403?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:45","pubTimestamp":1789955145,"startTime":"0","endTime":"0","summary":"On September 21, LEADS BIOLABS-B rose 5.29% in regular trading, trading at 58.8 HKD/share, with turnover of approximately 22.61 million HKD. The stock extended its rebound driven by a confluence of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"LEADS BIOLABS-B Rises on Morgan Stanley Upgrade to Overweight","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192173164","title":"Hong Kong Market Movers | LEADS BIOLABS-B (09887) Climbs Over 6% Pre-Noon as PD-L1/4-1BB Bispecific Antibody Unveils Updated Data at WCLC, Domestic Launch of LBL-024 Imminent","url":"https://stock-news.laohu8.com/highlight/detail?id=1192173164","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192173164?lang=en_us&edition=fundamental","pubTime":"2026-09-17 11:44","pubTimestamp":1789616654,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) saw its shares jump more than 6% in the morning session, trading up 5.73% at HK$57.20 as of the time of writing, with turnover reaching HK$103 million.On the news front, LEADS...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","BK4585","HK0000252160.HKD","VXUS","IPOS","09887","HK0000500386.USD","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146573399","title":"Movement Alert｜LEADS BIOLABS-B Rises 5.55% in Regular Trading, Technical Rebound After Two-Day Post-WCLC Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1146573399","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146573399?lang=en_us&edition=fundamental","pubTime":"2026-09-17 10:06","pubTimestamp":1789610791,"startTime":"0","endTime":"0","summary":"On September 17, LEADS BIOLABS-B rose 5.55% in regular trading, trading at 57.0 HKD/share, with turnover of approximately 53.75 million HKD. The rebound follows two consecutive trading days of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CLSA Lifts Target to 116.9 HKD as LEADS BIOLABS-B Rebounds","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188917631","title":"Movement Alert｜LEADS BIOLABS-B Falls 6.04% in Regular Trading, Stock Extends Post-WCLC Sell-the-News Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1188917631","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188917631?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:08","pubTimestamp":1789524509,"startTime":"0","endTime":"0","summary":"On September 16, LEADS BIOLABS-B fell 6.04% in regular trading, trading at 53.8 HKD/share, with turnover of approximately 46.66 million HKD, extending the prior session's sharp reversal pattern.On...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":145,"code":"91000000","status":"200"}]}}